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Abstract
Background: Neuroinflammation associated with Japanese encephalitis (JE) is mainly due to the activation of glial cells with
subsequent release of proinflammatory mediators from them. The recognition of viral RNA, in part, by the pattern
recognition receptor retinoic acid-inducible gene I (RIG-I) has been indicated to have a role in such processes. Even though
neurons are also known to express this receptor, its role after JE virus (JEV) infections is yet to be elucidated.
Methodology/Principal Findings: Upon infecting murine neuroblastoma cells and primary cortical neurons with JEV the
expression profile of key proinflammatory cyto/chemokines were analyzed by qRT-PCR and bead array, both before and
after ablation of RIG-I. Immunoblotting was performed to evaluate the levels of key molecules downstream to RIG-I leading
to production of proinflammatory mediators. Changes in the intracellular viral antigen expression were confirmed by
intracellular staining and immunoblotting. JEV infection induced neuronal expression of IL-6, IL-12p70, MCP-1, IP-10 and
TNF-a in a time-dependent manner, which showed significant reduction upon RIG-I ablation. Molecules downstream to RIG-
I showed significant changes upon JEV-infection, that were modulated following RIG-I ablation. Ablation of RIG-I in neurons
also increased their susceptibility to JEV.
Conclusions/Significance: In this study we propose that neurons are one of the potential sources of proinflammatory cyto/
chemokines in JEV-infected brain that are produced via RIG-I dependent pathways. Ablation of RIG-I in neurons leads to
increased viral load and reduced release of the cyto/chemokines.
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Introduction
Japanese encephalitis (JE) is the cause of recurrent epidemic viral
encephalitis in south-east Asia, with around 30,000–50,000 cases
reported every year resulting in 10,000 to 15,000 deaths [1]. The JE
virus (JEV) is a positive sense single stranded (ss) RNA virus, with
approximately 11 kb genome. JEV is a neuroptropic virus that
causes extensive neuronal death, which is reportedly mediated by
activatingthe tumornecrosisfactorreceptor(TNFR)-1complex[2].
One of the hallmarks of JEV infection is activation of microglia
which is associated with increased cell-proliferation and bioactive/
inflammatory mediator production associated with distinct mor-
phological changes. Although, certain activated glial-derived factors
contribute to tissue repair, the interactive cross-talk between
neuronal injury and microglial activation often determine the
neuropathological outcome in JEV infection. The functional
manifestations of such activated state are increased production of
proinflammatory mediators like cyto/chemokines, reactive oxygen
and nitrogen species by microglia. Increased release of proin-
flammatory mediators like tumor necrosis factor (TNF)-a, IL-1b,
IL-6, MCP-1 and RANTES have been observed from microglia
activated by JEV infection [3,4,5]. This release of cyto/chemokines
represent the innate immune response against flaviviral infection of
brain which in turn, is known to be mediated by the pattern
recognition receptors (PRRs) such as toll like receptors (TLRs) and
RIG-I–like receptors (RLRs) [6].
RIG-I, a type of RLR, recognizes double-stranded (ds) RNA
and uncapped 59 triphosphate RNA molecules, which are found in
the genome of many RNA viruses or produced during viral
replication. Interaction of viral RNA with RIG-I triggers several
intracellular signaling pathways leading to activation of host cell
cytokine gene expression and enhancement of other cellular
functions. The pathway leading to activation of nuclear factor kB
(NFkB) is activated by most, if not all, PRRs. NFkB plays a central
role in driving the expression of proinflammatory mediators [7].
RIG-I has also been shown to activate p38MAPK, leading to
secretion of CXCL-10, IL-12 and type-1 interferon in bone
marrow-derived dendritic cells following viral infection [8].
Although microglia and astrocytes are classically believed to be
the predominant source of these mediators in the brain, neurons
can also express these factors in disease settings [9,10]. JEV
tropism for neurons is a well established fact. Hence, it would be
plausible to assume that the neuronal PRRs play a certain role in
mediating the ultimate fate of the infected neurons. It has been
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e21761reported in earlier studies that JEV is recognized by RIG-I in
various cells of myeloid and non-immune lineage [11]; but
whether this is also true in neurons, is unknown. In recent years,
the ‘immune unresponsive’ status of the CNS has been challenged
by several studies. Apart from the glial cells, neurons have also
been implicated to participate in innate immune defense against
invading pathogens. The present investigation aims to determine
whether viral recognition is RIG-I-dependent in neurons and also
to evaluate role of the pathways downstream to RIG-I, in
induction of proinflammatory mediators from JEV-infected mouse
neurons.
Methods
Ethics statement
All animal experiments were approved by the Institutional
Animal and Ethics Committee of National Brain Research Centre
(approval nos. NBRC/IAEC/2007/36 and NBRC/IAEC/2008/
41). Animals were handled in strict accordance with good animal
practice as defined by Committee for the Purpose of Control and
Supervision of Experiments on Animals (CPCSEA), Ministry of
Environment and Forestry, Government of India.
Virus and cells
The GP78 strain of JEV was propagated in suckling BALB/c
mice and their brains were harvested when pathological symptoms
were observed. Virus titrations were conducted and quantified as
described earlier [12].
Mouse neuroblastoma Neuro2a (N2a) cells were obtained from
National Centre for Cell Science, Pune, India. Cells were grown at
37uC in Dulbecco’s modified Eagle medium (DMEM) supple-
mented with 3.7% sodium bi-carbonate (NaHCO3), 10% fetal
bovine serum and penicillin/streptomycin. All the reagents related
to cell culture were obtained from Sigma (St. Louis, USA), unless
otherwise stated.
Cortical neurons were cultured following published protocol
[13]. Briefly, cortices of P2 BALB/c mouse pups were dissected
aseptically in calcium-magnesium-free (CMF)-Tyrode solution
following decapitation. The meninges were removed, tissue were
chopped into smaller pieces and collected in CMF-Tyrode. These
were treated with trypsin DNAse and then dissociated in the same
solution by triturating to make a single cell suspension, pelleted
and resuspended in Neurobasal media. Neurobasal media was
supplemented with L-glutamine (2 mM), 30% glucose, 5% fetal
calf serum, 10% horse serum and penicillin–streptomycin. Cells
were plated at a density of 5610
3 cells/cm
2 onto poly-D-lysine-
coated Labtek chamber slides and 96-well plate (Nunc, Roskilde,
Denmark). After 48 h of incubation at 37uC, the serum containing
medium was removed. Cells were incubated with serum free
media for 4 h with antibiotics alone. For experimental treatments,
the resting medium was exchanged for DMEM with N2 and B27
supplements, 25 mM KCl and antibiotics. Arabinoside
(2610
25 M) was used for the inhibition of astrocyte multiplication.
Animal treatment
Five to six weeks old BALB/c mice of either sex were randomly
distributed into 4 groups- Sham, JEV-infected, JEV-infected and
treated with Vivo-morpholino against viral 39 conserved region
(JEV+39 MO) and JEV-infected and treated with scrambled Vivo-
Morpholino (JEV+S-MO). All Vivo-Morpholinos were commer-
cially procured from Gene Tools LLC, (Philomath, OR, USA).
Animals belonging to all groups except Sham were infected with
3610
5 plaque forming units (pfu) of JEV and that day was
considered as day zero. Animals in Sham group received equal
volume of filtered minimum essential media. Starting from 3 h
post infection on day zero, 100 mg of S-MO (59-ACTCCATCG-
TTCAGCCTCTGA-39), and 39 MO (59-TCCCAGGTGTCAA-
TATG CTCTT-39), diluted in 0.1 mL of sterile 16PBS (corres-
ponding to 5 mg/kg body weight), were administered to animals
belonging to JEV+S-MO and JEV+39 MO groups respectively,
once per day, for 5 consecutive days. Animals belonging to the
Sham-treatment group received equal volumes of sterile 16PBS
[14]. JEV-infected and JEV+S-MO animals succumbed by 8
th–9
th
day post infection. The animals belonging to the Sham, and
JEV+39 MO groups were also sacrificed at same time point. Brain
was excised out after repeated transcardial perfusion with ice-cold
16 PBS and were processed either for immunohistochemical
staining or protein isolation.
Infection and treatment schedule of neuronal cells
Cortical neurons were cultured in chamber slides in serum
containing media, for 26 h. Cells were then either mock-infected
or infected with JEV (2.3610
8 pfu/mL) at multiplicity of infection
(MOI) of 5 for 1K h. Cells were then washed twice with sterile 16
PBS to remove non-internalized virus and were incubated for 24 h
in serum free media.
N2a were plated and cultured in serum containing media until
70–80% confluency. Cells were transfected with either morpholino
directed against RIG-I (r-MO; 59-AATTTCTTGGTTTCAATG-
GGC-39) or a scrambled morpholino (Sc-MO; 59-GATAATTC-
TGGTTTTAAATTC-39), at 10 mM concentrations along with
specialized delivery moiety (endoporter) and incubated for 2 h at
37uC. These morpholinos and the endoporter were also procured
from Gene Tools LLC, (Philomath, OR, USA). Post incubation,
cells were infected with JEV as described above and were then re-
incubated with fresh morpholino-containing media for 24 h.
Mock-infected cells with and without morpholino treatments
served as controls; only JEV-infected cells, without morpholino
treatment served as positive control.
Determination of cell viability
N2a was plated onto separate 96-well plates in triplicate followed
by RIG-I ablation and JEV infection. Cell viability was assessed
using CellTiter 96 AQueous One Solution Cell Proliferation Assay
kit (Promega, USA) as described earlier [13]. 24 h post infection,
20 mL of MTS solution was added in each well. After 4 h
incubation in dark, the absorbance, reflecting the reduction of
MTS by viable cells was determined at 490 nm. Values were
expressed as a percentage relative to those obtained in mock-
infected cells.
Reactive oxygen species (ROS) generation assay
The level of intracellular ROS produced from different treatment
groups were measured by the cell permeable, non-polar, H2O2-
sensitive probe 5(and 6)-chlromethyl-20,70-dichlorodihydrofluores-
ceindiacetate (CM-H2DCFDA; Sigma, USA) as described earlier
[13] with certain modifications. The mean fluorescence intensity
was measured with the help of Varioskan Flash multimode reader
(Thermo Electron, Finland) at excitation 500 nm and emission
530 nm. The fluorescence intensity of intracellular DCFDA is a
linear indicator of the amount of H2O2 produced in the cells. The
measured mean fluorescence intensity was then normalized to equal
concentrations of protein in each sample.
Cytokine bead array
Mouse cytokine bead array (CBA) kits (BD Biosciences, San
Diego, CA) were used as per manufacturers’ instructions to
RIG-I in Japanese Encephalitis
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all the treatment groups. Data were acquired using Cell Quest Pro
Software in FACS Calibur and analyzed using BD CBA software
(Becton Dickinson, San Diego, CA, USA) [13].
Quantitative Real Time-PCR
Total cellular RNA from N2a treatment groups were
extracted using Tri reagent (Sigma, USA). Random hexamer
primers were used for cDNA synthesis using Advantage RT-
PCR (Clontech, Mountain View, USA). cDNA were then
subjected to mouse TLR signaling pathway PCR array (SA
Biosciences, MD, USA) as per manufacturers instruction on a
ABI Prism 7500 sequence detection system (Applied Biosystems,
CA, USA). The real time PCR results were analyzed as per user
manual guidelines and expressed as fold-changes over mock-
infected.
Immunostaining
M o u s ec o r t i c a ln e u r o n a lc e lls were cultured in 4-well
chamber slides and were either mock-infected or infected with
JEV as described above. After 24 h of incubation, the cells were
fixed in 4% paraformaldehyde and blocked with 5% BSA
solution. The cells were then incubated overnight at 4uCw i t h
primary antibodies against RIG-I and NeuN (1:500; Chemicon,
USA). Following incubation, the cells were washed and incu-
bated with appropriate fluorochrome-conjugated secondary
antibodies. After final washes cells were mounted with 49-6-
diamidino-2-phenylindole (DAPI, Vector laboratories Inc., CA,
USA).
N2a were cultured in 8-well chamber slides and were treated
with morpholinos followed by infection with JEV, as described
under section infection and treatment schedule. The cells were
immunostained using primary antibodies against phosphoNFkB
(1:250, Cell signaling, USA) and phosphoP38MAPK (1:250, Cell
signaling, USA) as described above. The slides were observed
under a Zeiss Axioplan 2 Fluorescence microscope and images
were captured using the AxioVision Rel 4.6 software (Carl Zeiss,
CA, USA).
Viral intracellular staining
N2a were plated in 60 mm culture plates and were treated as
described above. After 24 h of incubation, cells were collected
by washing with chilled sterile 16 PBS. After two washes with
16 PBS, cells were first fixed with BD cytofix solution (BD
Biosciences) and permeabilized by resuspending in permeabiliza-
tion buffer (BD Cytoperm plus; BD Biosciences). Cells were then
washed twice in wash buffer (PBS containing 1% bovine serum
albumin) and finally resuspended in wash buffer at 1610
6 cells per
100 mL. They were then treated with primary antibody (JEV
Nakayama strain; Chemicon, USA; 1:100 dilutions) for 30 min
at room temperature. Cells were then washed and pelleted
by centrifugation followed by incubation with FITC-conjugated
secondary antibody for 30 min. After final wash, cells were
resuspended in 400 mL FACS buffer and analyzed on a FACS
Calibur. The percentage of population of JEV-positive cells was
calculated after gating the populations on a Dot plot using Cell
Quest Pro Software (BD Biosciences).
Total cellular and nuclear protein extraction
N2a were seeded at a density of 5610
6 cell per 90-mm culture
plates and were treated as described above. Mock-infected and
treated N2a were collected using ice-cold 16 PBS. In order to
obtain total cellular extracts, cells were lysed in buffer containing
1% Triton-X-100, 10 mM Tris-HCl (pH 8.0), 150 mM NaCl,
0.5% Nonidet P (NP-40), 1 mM EDTA, 0.2% EGTA, 0.2%
sodium orthovanadate and protease inhibitor cocktail (Sigma,
USA). To obtain nuclear extracts cells were washed twice with ice-
cold PBS and pelleted. The cell pellet was resuspended in
hypotonic buffer (10 mM HEPES, pH 8.0; 10 mM KCl; 5 mM
dithiothreitol; 0.5 mM phenylmethylsulfonyl fluoride; 1 mM
Na3VO4) and incubated on ice for 15 min. Then the cells were
lysed by the addition of 0.5% IGEPAL CA 630 and vigorous
vortexing for 30 s. The nuclei were pelleted by centrifugation at
12,0006 g for 1 min at 4uC and resuspended in extraction
buffer (20 mM HEPES, pH 8.0; 420 mM NaCl; 0.2 mM
EDTA; 1 mM dithiothreitol; 0.5 mM phenylmethylsulfony fluo-
ride; 1 mM Na3VO4). After 15 min on ice, lysates were
centrifuged at 12,0006 g for 10 min at 4uC [15]. Supernatants
were collected and stored at 230uC. Protein levels were estimated
by bicinchoninic assay (BCA) method.
Immunoblotting
Western blot analysis was performed to study modulation in
expression of proteins post treatment, from total cellular or nuclear
extracts, using primary antibodies against JEV NS5 (a kind gift
from Dr. Chun-Jung Chen, Taichung Veterans General Hospital,
Taichung, Taiwan), Caspase 8, C23, FADD, TRAF-6, (kind gifts
from Dr. Ellora Sen, NBRC), IPS-1 (Sigma, USA), RIG-I,
phospho IKKa/b,I kBa, phospho and total NFkB, and phospho
and total p38MAP kinase (Cell Signalling, USA) at 1:1000
dilutions. After extensive washes with PBS–Tween, blots were
incubated with appropriate peroxidase-conjugated secondary
antibodies (Vector Laboratories, CA, USA). The blots were
processed for development using chemiluminescence reagent
(Millipore, USA). The images were captured and analyzed using
Chemigenius, Bioimaging System (Syngene, Cambridge, UK). To
determine equivalent loading of samples the blots were stripped
and reprobed with anti-b-tubulin (Santa Cruz Biotechnology, CA,
USA).
Statistical analysis
Data were compared between groups using one-tailed
Student’s T Test. Statistical significance was set at p,0.05 for
all analyses.
Results
JEV causes upregulation of RIG-I both in vivo and in vitro
Immunohistochemical analysis of brain sections of Sham,
JEV-infected and JEV+39 M Og r o u po fm i c es h o w e dt h a tt h e r e
was prominent expression of RIG-I in JEV-infected group.
However, viral inhibition by application of 39 MO resulted in
RIG-I expression that was comparable to Sham (Fig. 1A).
Immunoblot analysis from whole brain lysates confirmed
significant increase of RIG-I in JEV-infected or JEV+S-MO
groups that was drastically reduced following treatment with 39
MO (p,0.05) (Fig. 1B&C). RIG-I expression was also found to
be enhanced following JEV infection in cultured primary cortical
neurons (Fig. 1D). Immunoblotting from N2a cells post 12 h and
24 h of infection showed significant increase in RIG-I, when
compared to mock-infected cells. However, there was no
significant difference in RIG-I levels between the two time
points (Fig. 1E&G). Application of rMO resulted in approxi-
mately 50% reduction in RIG-I level even after 24 h post JEV
infection (p,0.05) (Fig. 1F&H).
RIG-I in Japanese Encephalitis
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expression of RIG-I, that was co-localized with neuron-specific marker NeuN, as compared to sham. Blocking of virus using 39MO resulted in reduced
detection of RIG-I in the brain. Magnification 620; scale bar corresponds to 50 m (A). Immunoblotting from whole brain lysates and their
densitometric analysis showed increased (approximately 5-fold) expression of RIG-I in JEV-infected and JEV+S-MO groups. 39MO treatment caused a
significant decrease in RIG-I levels. (
*p,0.05 when compared to JEV-infected) (B&C). Primary cortical neurons were cultured and stained for RIG-I
following JEV infection. A prominent increase in RIG-I expression was observed when compared to mock-infected cells (D). N2a after JEV-infection
showed increased expression of RIG-I both 12 and 24 h post-infection (E&G). Treatment with r-MO resulted in significant reduction in RIG-I
expression; (
*p,0.05 when compared to JEV-infected). Data is representative of 3 independent experiments (F&H).
doi:10.1371/journal.pone.0021761.g001
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molecules downstream to RIG-I leading to activation of
p38MAPK and NFkB
Post JEV infection, the level of molecules associated with
RIG-I signaling was investigated by immunoblotting. It was
observed that the levels of IPS-1, TRAF 6 and active Caspase 8
were significantly increased both after 12 and 24 h post
infection, whereas the levels of phosphoIKKa/b and FADD
were only increased after 24 h (p,0.05). IkBa, phosphoNFkB
and phosphoP38MAPK levels were found to be decreased
significantly (p,0.05) after 24 h post infection compared to
12 h post infection groups (Fig. 2). Following RIG-I inhibition, it
was seen that phosphoIKKa/b, FADD, IPS-1, TRAF 6 and
active Caspase 8 levels were significantly reduced 24 h post
infection when compared to only JEV-infected or JEV+Sc-MO
group (p,0.05) , while the level of IkBa was significantly
increased (p,0.05) (Fig. 3). Treatment of mock-infected cells
with only rMO did not result in any significant change in the
expression levels of these molecules (Fig. S1A–F) which shows
that the changes were due to the virus infection. Immunocyto-
chemical staining revealed increased expressions of phosphor-
ylated form of NFkB and P38MAPK was expressed in higher
degree 24 h post infection when compared to mock-infected
cells. However, following rMO treatment, their levels were
found to be comparable to mock-infected cells even after 24 h of
JEV infection (Fig. 4A&B). Immunoblotting from nuclear
extracts of cells from all the treatment groups showed
significantly increased levels of both phosphoNFkBa n d
Figure 2. Temporal changes in the levels of key signaling molecules in neurons leading to activation of P38MAPK and NFkB, post
infection with JEV. Immunoblotting for molecules downstream to RIG-I was performed from protein isolated from N2a, 12 and 24 h post infection
with JEV. TRAF-6, IPS-1 and active Caspase8 levels in JEV-infected N2a showed significant increases both 12 and 24 h post-infection, but phospho
IKKa/b and FADD levels were increased significantly only after 24 h post-infection when compared to mock-infected (A–E & G). The level of IkBa was
found to be significantly lower in 24 h post-infected group when compared to 12 h post-infected group (A&F). PhosphoP38MAPK and phosphoNFkB
levels were found to be considerably increased after 12 h post-infection as compared to mock-infected. But after 24 h their levels were significantly
lesser than 12 h post infection groups (A, H & I). (
*p,0.05 when compared to mock-infected;
#p,0.05 when compared to 12 h post-infected). Data is
representative of 3 independent experiments.
doi:10.1371/journal.pone.0021761.g002
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compared to mock-infected (p,0.05). After RIG-I inhibition,
their levels were found to be significantly decreased when
compared to JEV-infected group (p,0.05) (Fig. 4C–E).
Transcriptional alterations of certain signaling molecules
associated with RIG-I following JEV infection
Quantitative real time PCR was carried out to determine the
transcriptional changes in certain effectors and downstream
target genes associated with RIG-I. Specifically, the expression of
effector molecules such as Caspase 8, FADD, IRAK 1 and
TRAF 6 were found to be significantly increased following JEV
infection. Among the downstream target genes, the levels of
MCP-1, CXCL-10, CHUK, GMCSF, IL-6, IL-2, CLEC4E, IL-
6Ra,N F kB-1 and Rel were also found to be significantly
increased. On ablating RIG-I with the application of rMO, it
was found that there was significant decrease in all the studied
effector molecules. Amongst the studied downstream molecules
all, except NFkB-1, IL-6Ra and IL-2, showed significant
decreases when compared to JEV-infected group (p,0.05). IL-
2 level was found to be significantly increased after rMO
treatment (p,0.05) (Fig. 5).
Ablation of RIG-I abrogates secretion of proinflammatory
cyto/chemokines from neurons following JEV infection
The release of proinflammatory cyto/chemokines viz. IL-12,
TNF-a, MCP-1 and IL-6, were found to be significantly elevated
both 12 and 24 h post JEV infection when compared to that
from respective time-matched mock-infected cells (p,0.05)
(Fig. 6A–D). However, ablation of RIG-I resulted in significant
reduction in their levels 24 h post infection with JEV when
compared to only JEV-infected or JEV+Sc-MO group (p,0.05)
(Fig. 7A–D). rMO itself did not cause appreciable change in
cytokine levels (Fig. S1G–J).
Figure 3. Ablation of neuronal RIG-I decreases the levels of key signaling molecules post JEV-infection. Following ablation of RIG-I and
24 h post infection with JEV, the levels of certain downstream elements of the RIG-I pathway were evaluated by immunoblotting protein isolated
from N2a. PhosphoIKKab, TRAF-6, FADD, IPS-1 and active Caspase8 levels in JEV+rMO group showed significant decreases when compared to JEV-
infected groups (A–F). The level of IkBawas found to be significantly increased in JEV+rMO when compared to JEV-infected group (A & G) (
#p,0.05
when compared to JEV-infected group,
*p,0.05 when compared to JEV-infected group). Data is representative of 3 independent experiments.
doi:10.1371/journal.pone.0021761.g003
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survivability and generation of oxidative stress in N2a
Flow cytometric analysis showed increased presence of viral
antigen after intracellular staining in JEV+rMO group when
compared to JEV-infected or JEV+Sc-MO groups (Fig. 8A).
Immunoblot analysis of viral NS5 also showed significant
increase in JEV+rMO group when compared to JEV-infected
or JEV+Sc-MO groups (p,0.05) (Fig. 8B&C). MTS assay
performed on all treatment groups showed reduced surviv-
ability in JEV-infected or JEV+Sc-MO groups when com-
pared to mock-infected, though the change was not statisti-
cally significant. However, in the JEV+rMO group
survivability was significantly decreased when compared to
mock-infected, JEV-infected or JEV+Sc-MO groups (p,0.05)
(Fig. 8D). Generation of oxidative stress is a hallmark of JEV-
infected cells. Here, we found that ROS levels were
significantly increased in JEV-infected or JEV+Sc-MO groups
when compared to mock-infected groups. However, in
JEV+rMO group, the ROS level was found to be even higher
than either JEV-infected or JEV+Sc-MO groups (p,0.05)
(Fig. 8E).
Discussion
Multiple cell types in the body have been reported to be capable
of sensing flaviviral infections and initiating innate immune
responses. Double stranded (ds)RNA, generated during infection
as a replication intermediate for RNA viruses, serve as pathogen-
associated molecular pattern that can be recognized by several
PRRs. RIG-I, a cytoplasmic protein that has been shown to be a
detector of dsRNA as well as ssRNA with 59 triphosphates [16].
Recognition of flaviviruses through RIG-I has been reported [17]
that results in type I interferon and proinflammatory cyto/
chemokine production from cells of the myeloid lineage [18]. In
Figure 4. Decrease in levels of activated P38MAPK and NFkB in JEV-infected neurons post RIG-I ablation. Mock-infected, JEV-infected
and JEV+rMO treated N2a were stained for the detection of pP38MAPK and pNFkB, 24 h post infection. Photomicrographs show decreased
expression of either of them in JEV+rMO when compared to JEV-infected groups. Magnification 620; scale bar corresponds to 50 m (A&B)
Immunoblotting for these molecules from nuclear extracts of all the groups of cells showed considerable decreases in JEV+rMO groups when
compared to JEV-infected groups. The data were normalized to mouse nuclear protein C23 (C–E). (
*p,0.05 when compared to mock-infected,
#p,0.05 when compared to JEV-infected). Data is representative of 3 independent experiments.
doi:10.1371/journal.pone.0021761.g004
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primarily respond to intracellular accumulation of viral dsRNA via
RIG-I [19]. Specifically, RIG-I has been shown to be essential in
the identification of JEV for the production of type I interferon in
Vero (epithelial) cells [20].
The innate immune responses of neurons following JEV infection
is poorly understood as the CNS has for long, been considered as an
‘immune privileged’ organ. It has been reported that PRRs are
expressed in neurons [21]. RIG-I is basally expressed in undetectable
levels in uninfected neurons [22], though recent studies suggest that it
plays a prominent role in mediating innate immune response,
followingviralinfections[23].In thisstudy,priortoJEVinfection,we
found very low expression of RIG-I both in whole brain and in
cultured neurons. JEV predominantly infects neurons, following
which RIG-I was found to be expressed in significantly higher levels
in brain. As after inhibiting the virus using an antisense molecule (39
MO) no significant alteration in RIG-I expression was observed from
non-infected brain samples, it can be safely assumed that JEV causes
upregulation of this PRR in various CNS cell types, including
neurons. Upon recognition of viral RNA, the caspase recruitment
domain (CARD)-like motif of RIG-I gets activated and interacts with
interferon promoter stimulator-1 (IPS-1) to relay the signal. The
signal is divided at IPS-1, resulting in activation of NFkBa n dI R F - 3
and -7 [7]. Post JEV infection, IPS-1 expression was found to be
Figure 5. Gene expression profile of downstream pathways and target genes associated with RIG-I. N2a were mock-infected, JEV-
infected or JEV-infected and treated with rMO, followed by incubation for 24 h. Total RNA was extracted for quantitative real time PCR (qRTPCR) array
analysis. The data are normalized to mouse b-actin messenger RNA (mRNA) and are expressed as the relative fold increase over normalized RNA from
mock infected cells. Data is representative of 2 independent experiments. (
*p,0.05 when compared to JEV-infected,
#p,0.05 when compared to
JEV-infected).
doi:10.1371/journal.pone.0021761.g005
Figure 6. Neuronal proinflammatory cyto/chemokine profile following JEV infection at different time points. Cytometric bead array
performed from culture supernatants obtained from JEV-infected N2a, 12 h and 24 h post infection showed that IL-12p70, TNF-a, IL-6 and MCP-1
levels were significant increased in comparison to respective time-matched mock-infected groups (A–D) (
*p,0.05, when compared to mock-infected
after 12 h,
#p,0.05, when compared to mock-infected after 24 h). Values are mean 6 SD of 3 independent experiments.
doi:10.1371/journal.pone.0021761.g006
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molecule FADD. Apart from its role in apoptotic process, FADD is
also known to activate TNF receptor-associated factor 6 (TRAF 6),
which was found to be increased following JEV infection in neurons.
TRAF 6 activates IkBk i n a s ea/b (IKKa/b) via Tak1 leading to
phosphorylation of IkBa-NFkB complex. JEV infection leads to
decreased level of IkBa, at later time point indicating its dissociation
from the complex followed by proteolytic degradation. Since the
removal of the inhibitory effect of IkBa,N F kB is activated and
translocated into the nucleus to modulate the expression of
proinflammatory cyto/chemokine genes. We found increased level
of phospho NFkB in neuronal cells following JEV infection. Its level
in nuclear extract of these cells was also increased. Activation of
p38MAPK has been shown to be associated with the activation of
RIG-I via TRAF 2-TAK 1 dependent pathway [8] in non-neuronal
cells. Whether this also occurs in neurons was previously unknown.
Here we have shown for the first time that following JEV infection,
phospho p38MAPK levels are significantly increased in neurons as
evident from immunocytochemical observations and also from
immunoblot analysis of nuclear extracts obtained from infected cells.
Both NFkB and p38MAPK are well known stimulators of
proinflammatory cyto/chemokine gene expression, and their upre-
gulation was concurrent with elevated secretions of IL-12, TNF-a,
MCP-1 and IL-6 and increased expression of CXCL-10 (IP-10),
GMCSF from infected neuronal cells. RIG-Iinhibition carried out by
transfecting cells with rMO resulted in downregulation of phos-
phoIKKab,T R A F6 ,I P S - 1 ,F A D D ,a n da c t i v eC a s p a s e8 ,e x c e p t
IkBa, which showed significant increase indicating its inhibitory
effects on NFkB. Subsequently, it was observed that phospho NFkB
and phospho p38MAPK levels were decreased that led to reduction
in the levels of the proinflammatory mediators.
An interesting observation was that neuronal survivability was
negatively affected following RIG-I inhibition. JEV-infection
results in development of oxidative stress and leads to apoptotic
death of neuronal cell lines [24]. Ablation of RIG-I was found to
be associated with decreased survivability and increased stress in
the cells in comparison to only JEV infected cells. This was
concomitant with increased intracellular viral load, as shown by
immunoblot and flow cytometric analysis. This phenomenon
may be due to the fact the antiviral innate immune response is
subverted following RIG-I ablation and this observation merits
further studies. Thus, it is clear from this study that viral sensing
Figure 7. Comparison of proinflammatory cyto/chemokine profile following JEV infection pre- and post- ablation of RIG-I. Following
JEV infection and treatment with either Sc-MO or rMO, the cyto/chemokine levels showed significant increases in supernatants from JEV-infected and
JEV+Sc-MO groups. However, significant reductions were observed in their levels following RIG-I ablation, 24 h post-incubation (A–D). (
*p,0.05,
when compared to mock-infected,
# p,0.05, when compared to JEV-infected). Values are mean 6 SD of 3 independent experiments.
doi:10.1371/journal.pone.0021761.g007
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(Fig. 9) that cause the infected neurons to participate in the
inflammatory milieu in CNS which ultimately leads to their own
demise. However, the concerted role of other PRRs cannot be
ruled out at this point of time. Since there are other sensors
present in cells such as TLRs, PKR, MDA5 and MPYS, a co-
Figure 8. Increased oxidative stress, viral load and decreased survivability of N2a following RIG-I ablation. Flow cytometric analysis
carried out from cells of all treatment groups to detect intracellular JEV antigen showed significant increase post RIG-I ablation when compared to
only JEV-infected or JEV+ScMO groups. The mean fluorescence intensities obtained from each group are depicted in the figure. (1-Unstained, 2-Mock-
infected; 3-JEV-infected, 4-JEV+Sc-MO, 5-JEV+rMO) (A). Immunoblot analysis to detect JEV NS-5 expression also showed enhancement in JEV+rMO
when compared to either JEV-infected or JEV+ScMO groups (B&C). (
*p,0.05, when compared to mock–infected,
#p,0.05 when compared to JEV-
infected group). No statistically significant change in the viability of N2a post 24 h of JEV-infection was observed. However, RIG-I ablation resulted in
significantly decreased viability compared to mock-infected as well as JEV-infected groups (D). (
**p,0.05 when compared to mock-infected;
##p,0.05 when compared to JEV-infected). ROS production, a hallmark of JEV infection, showed significant increases in JEV-infected and JEV+Sc-MO
groups when compared to mock-infected groups which on RIG-I ablation showed further increase even when compared to JEV-infected group (E).
(
*p,0.05 when compared to mock-infected;
#p,0.05 when compared to JEV-infected). Data is representative of 3 independent experiments.
doi:10.1371/journal.pone.0021761.g008
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infection.
Supporting Information
Figure S1 The antisense rMO treatment of mock-
infected cells does not result in modulation of down-
stream signaling molecules or proinflammatory cyto/
chemokine release. On application of rMO to mock-infected
cells, the expression levels of TRAF6, IPS-1, active Caspase 8,
IkBa and FADD were found not to be significantly different from
that observed in only mock-infected cells (A–F). To check
whether rMO induced proinflammatory cytochemokine release
from cells, CBA was performed from culture supernatants.
Results showed that there were no significant differences between
the cyto/chemokine levels in mock-infected and mock-infec-
ted+rMO treated groups (G–J). Data is representative of 2
independent experiments.
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Figure 9. Schematic diagram showing RIG-I signaling pathway leading to production of proinflammatory cyto/chemokines from
neurons. Detection of viral ss/dsRNA by RIG-I activates a cascade of changes that leads to activation of P38MAPK and NFkB. As a result of such
activation, proinflammatory cyto/chemokine gene transcription is enhanced in neurons that ultimately contribute to the inflammatory milieu in the
brain, following JEV infection. Ablation of RIG-I using antisense morpholino oligonucleotide results in negative modulation of this pathway.
q-upregulation; Q-downregulation; w -ablation.
doi:10.1371/journal.pone.0021761.g009
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